Exploding head syndrome: clinical features, theories about etiology, and prevention strategies in a large international sample.

Differential diagnosis Episodic cranial sensory shocks Etiology Exploding head syndrome Parasomnia

Journal

Sleep medicine
ISSN: 1878-5506
Titre abrégé: Sleep Med
Pays: Netherlands
ID NLM: 100898759

Informations de publication

Date de publication:
11 2020
Historique:
received: 25 03 2020
revised: 25 05 2020
accepted: 26 05 2020
pubmed: 31 8 2020
medline: 22 6 2021
entrez: 31 8 2020
Statut: ppublish

Résumé

Exploding head syndrome (EHS) is a benign sensory parasomnia characterized by the perception of loud noises or a sense of explosion in the head. Few studies have assessed clinical features and little is known about demographic differences or prevention strategies. A cross-sectional study of 3286 individuals with and 2954 without lifetime EHS episodes was conducted via online questionnaires. Those with EHS had shorter sleep durations, longer sleep onset latencies, poorer sleep quality, and less sleep efficiency, but effect sizes for these differences were small. Females were slightly more likely than males to endorse EHS. 44.4% of individuals with EHS experienced significant fear during episodes, but fewer reported clinically significant distress (25.0%) or interference (10.1%) as a result of EHS. Most sufferers believed it to be a brain-based phenomenon, but a small minority endorsed anomalous causes. Five prevention strategies with >50% reported effectiveness were identified. EHS was assessed in the largest sample to date. Though associated with clinical impacts, no empirically supported interventions yet exist. The five prevention strategies may prove useful for treatment development.

Identifiants

pubmed: 32862013
pii: S1389-9457(20)30260-4
doi: 10.1016/j.sleep.2020.05.043
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

251-255

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Auteurs

Brian A Sharpless (BA)

Department of Psychology, St, Mary's College of Maryland, USA; Department of Psychology, Goldsmiths, University of London, United Kingdom. Electronic address: basharpless@gmail.com.

Dan Denis (D)

Department of Psychology, University of Notre Dame, Indiana, USA.

Rotem Perach (R)

School of Psychology, University of Sussex, Brighton, United Kingdom; Department of Psychology, Goldsmiths, University of London, United Kingdom.

Christopher C French (CC)

Anomalistic Psychology Research Unit, Goldsmiths, University of London, United Kingdom.

Alice M Gregory (AM)

Department of Psychology, Goldsmiths, University of London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH